Allarity Therapeutics Inc (NASDAQ:ALLR)’s traded shares stood at 4.33 million during the last session, with the company’s beta value hitting 0.00. At the close of trading, the stock’s price was $1.00, to imply an increase of 17.58% or $0.15 in intraday trading. The ALLR share’s 52-week high remains $216.00, putting it -21500.0% down since that peak but still an impressive 32.0% since price per share fell to its 52-week low of $0.68. The company has a valuation of $4.43M, with an average of 2.67 million shares in intraday trading volume over the past 10 days and average of 2.65 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Allarity Therapeutics Inc (ALLR), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give ALLR a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.
Allarity Therapeutics Inc (NASDAQ:ALLR) trade information
After registering a 17.58% upside in the last session, Allarity Therapeutics Inc (ALLR) has traded red over the past five days. The 5-day price performance for the stock is -1.96%, and 0.02% over 30 days. With these gigs, the year-to-date price performance is -14.53%. Short interest in Allarity Therapeutics Inc (NASDAQ:ALLR) saw shorts transact 0.66 million shares and set a 0.44 days time to cover.
ALLR Dividends
Allarity Therapeutics Inc has its next earnings report out on 2024-Nov-13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Allarity Therapeutics Inc (NASDAQ:ALLR)’s Major holders
Allarity Therapeutics Inc insiders hold 16.80% of total outstanding shares, with institutional holders owning 2.36% of the shares at 2.83% float percentage. In total, 2.36% institutions holds shares in the company.
We also have Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund as the top two Mutual Funds with the largest holdings of the Allarity Therapeutics Inc (ALLR) shares. Going by data provided on Dec 31, 2024, Fidelity Extended Market Index Fund holds roughly 7.19 shares. This is just over 0.16% of the total shares, with a market valuation of $7192.0. Data from the same date shows that the other fund manager holds a little less at 1.93, or 0.04% of the shares, all valued at about 1934.0.
